Edwards Lifesciences Corporation · NYSE:EW
Edwards Lifesciences — TCT 2022
8 slides from Edwards Lifesciences's conference presentation, Sep 17, 2022
Slide 1: Edwards Lifesciences TCT 2022 Investor Update
Edwards Lifesciences TCT 2022 Investor Update September 17, 2022
Slide 2: Cautionary Statement
Cautionary Statement Presentations and comments made today by management of Edwards Lifesciences Corporation (the “Company”) will include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as
Slide 3: TCT 2022 Investor Update Agenda
TCT 2022 Investor Update Agenda
Slide 4: CLASP IID Synopsis and PASCAL Experience
CLASP IID Synopsis and PASCAL Experience Bernard Zovighian Ted Feldman, MD Scott Lim, MD Corporate Vice President SVP, Medical Affairs Professor of Medicine & Pediatrics Transcatheter Mitral and Tricuspid Transcatheter Mitral and at the University of Virginia and Therapies Tricuspid Therapies Medica
Slide 5: TMTT Q&A
et + + + F+ttee¢tt¢++4- ttt tte e es F+tte+¢tt++s tet tte ttt tttttttets t+tttee t+ tttt+++44 t+tt+et+ tttttt++ t+tt+4+4+- ttttttt t+tt+4+4 ttttt+ t+t+t++4 t+tt+ beet
Slide 6: SAPIEN 3 Ultra RESILIA and SAPIEN X4
SAPIEN 3 Ultra RESILIA and SAPIEN X4 Larry Wood David Wood, MD Corporate Vice President Director, UBC Centre of Cardiovascular Innovation Transcatheter Aortic Valve Head, Division of Cardiology, Vancouver Replacement Professor of Medicine, University of British Columbia
Slide 7: TAVR Q&A
et + + + F+ttee¢tt¢++4- ttt tte e es F+tte+¢tt++s tet tte ttt tttttttets t+tttee t+ tttt+++44 t+tt+et+ tttttt++ t+tt+4+4+- ttttttt t+tt+4+4 ttttt+ t+t+t++4 t+tt+ beet
Slide 8: P| oP TN
P| oP TN Re ND, ve Edwards